Results 1 to 10 of about 87,683 (298)

Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species [PDF]

open access: yesAntimicrobial Resistance and Infection Control, 2016
Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients.
Annelien Everaert, Tom Coenye
doaj   +4 more sources

Sulbactam: A β–Lactam Compound with Neuroprotective Effects in Epilepsy [PDF]

open access: yesNeurology International
Background: The pathophysiology of epilepsy is characterized by increased neuronal activity due to an excess of the excitatory neurotransmitter glutamate and a deficiency in the inhibitory neurotransmitter gamma–aminobutyric acid (GABA).
Fang-Chia Chang   +8 more
doaj   +2 more sources

Hypericin enhances β-lactam antibiotics activity by inhibiting sarA expression in methicillin-resistant Staphylococcus aureus [PDF]

open access: yesActa Pharmaceutica Sinica B, 2019
Bacteremia is a life-threating syndrome often caused by methicillin-resistant Staphylococcus aureus (MRSA). Thus, there is an urgent need to develop novel approaches to successfully treat this infection.
Genzhu Wang   +8 more
doaj   +3 more sources

Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon? [PDF]

open access: yesAntibiotics
Pseudomonas aeruginosa is a significant threat to public health as an aggressive, opportunistic pathogen. The use of β-lactam antibiotics such as penicillins, cephalosporins, monobactams, and carbapenems remains a front-line treatment against P ...
Dylan W. Zhao, Christopher T. Lohans
doaj   +2 more sources

Unraveling the mechanisms behind the enhanced efficacy of β-lactam-based sideromycins [PDF]

open access: yesCommunications Biology
Previous studies have explored combining β-lactams with siderophores to create Trojan horse molecules that can penetrate the outer membrane of Gram-negative bacteria via TonB-dependent transporter (TBDT).
Evelyne Lacasse   +8 more
doaj   +2 more sources

β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward

open access: yesFrontiers in Microbiology, 2023
β-lactam antibiotics are one of the most widely used and diverse classes of antimicrobial agents for treating both Gram-negative and Gram-positive bacterial infections.
Lekshmi Narendrakumar   +4 more
doaj   +1 more source

β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value

open access: yesCritical Care Explorations, 2022
OBJECTIVE:. β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24–48 hours after the initiation of therapy in ...
Thomas J. Dilworth, PharmD   +4 more
doaj   +1 more source

1,4-diacetoxy-β-lactams. Reactions with nucleophiles [PDF]

open access: yes, 1985
β-Lactam reacts with hetero nucleophiles under ring cleavage to give 2,2-dimethyl-3-oximinobutanoic esters 6 and 7 .
Elburg, P.A. van   +3 more
core   +6 more sources

The state and consideration for skin test of β-lactam antibiotics in pediatrics

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
β-lactam antibiotics are the most frequently used drugs and the most common drugs that cause allergic reactions in pediatrics. The occurrence of some allergic reactions can be predicted by skin testing, especially severe adverse reactions such as ...
Chunhui Gao   +3 more
doaj   +1 more source

Image-based dynamic phenotyping reveals genetic determinants of filamentation-mediated beta-lactam tolerance [PDF]

open access: yes, 2020
Antibiotic tolerance characterized by slow killing of bacteria in response to a drug can lead to treatment failure and promote the emergence of resistance.
Camacho, Rafael   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy